Astra vaccine is not suitable for the elderly…獨 Preventive effect over 65 years old 8

AstraZeneca vaccine [사진=로이터 연합뉴스]

Controversy has arisen over whether the COVID-19 (new coronavirus infection) vaccine jointly developed by AstraZeneca and Oxford University in the UK is effective for the elderly. It is observed that the European Medicines Agency (EMA) can grant approval for use only to young people.

According to the British Guardian and BBC Broadcasting, the Commissioner of the European Medicines Agency (EMA) attended the European Parliament’s Health Committee on the 26th (local time) to answer questions from lawmakers, excluding the possibility of approving AstraZeneca vaccines only for certain age groups. Did not do it.

“We don’t want to be confused because there is a scientific and professional discussion going on,” he said. “There is a possibility that a conclusion will be made to approve use by focusing on a specific age group, and a conclusion may be drawn to target a wider age group.” .

Commissioner Cook said, “AstraZeneca vaccine is effective for the elderly, and studies have been conducted with only a small number of people.” “What the research data means about the population for which the study has been conducted, as well as the population that has not been studied. We are trying to find out what is expected (when vaccinated),” he added.

EMA is currently reviewing approval for conditional marketing of the AstraZeneca vaccine. The screening results are scheduled to be released on the 29th.

Controversy that the AstraZeneca vaccine is not effective for the elderly has recently flowed into the German media. German economic journal Handelsblatt quoted a government official on the 25th and reported that the AstraZeneca vaccine prevented only 8% of the elderly over the age of 65. Daily Bild also released a similar report on the same day.

Since then, the two newspapers also reported that the EMA will not approve the use of the AstraZeneca vaccine to the elderly over 65 years old. AstraZeneca, on the other hand, refuted that it was “completely misleading.”

AstraZeneca vaccine [사진=EPA 연합뉴스]

AstraZeneca said, “According to the data we published last November in the Lancet (academic journal), the elderly showed a strong immune response from vaccination,” he said. “After the second vaccination, the generation of antibodies in the elderly reached 100%.” .

He stressed that the Joint Committee on Vaccination and Immunization (JCVI) in the UK has approved the use of older people.

Pascal Sorio AstraZeneca, CEO of AstraZeneca, also said, “I have no idea where the source of the false claim is,” he said in an interview with German Devel. Said.

Reporter Kang Kyung-joo [email protected]

Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution